Researchers at Baylor College of Medicine and collaborating institutions are developing a strategy to predict the response of triple negative breast cancer (TNBC) to chemotherapy, which would be a valuable tool for physicians deciding on the treatment with better probability of success on an individual basis. The study appears in Cancer Research Communications , a journal of the American Association for Cancer Research . "Multiple research innovations in cancer diagnostics are on display in this work," said co-corresponding author Dr.
https://www.miragenews.com/kipa-may-predict-chemotherapy-response-in-1050873/#miragenews
You must login before you can post a comment.